ACTO Launches ACTOverse: A New Digital Marketplace for Life Sciences Solutions

On November 5, 2025, at the Veeva Commercial Summit in Madrid, ACTO, a leader in AI-driven solutions for the life sciences, introduced ACTOverse, a digital marketplace dedicated to connecting biopharma and medical technology companies with high-quality partner solutions. This initiative is part of ACTO's ongoing mission to enhance field excellence through innovation and efficiency.

What is ACTOverse?

ACTOverse is designed as a curated ecosystem that integrates various partner solutions into the ACTO platform. It aims to simplify the process of discovering, evaluating, and utilizing supplementary content, data, and services essential for training and qualifying teams in the life sciences sector. ACTOverse features three primary categories of partners:

1. Content Partners: These partners provide extensive catalogs of standardized and customized training courses, reference materials across therapeutic areas, and clinical sciences, ensuring that sales teams can prepare efficiently for product launches, role-playing, and certifications.
2. Data Partners: This category offers market research, healthcare professional (HCP) profiling, and data regarding patient experiences, enabling companies to tailor learning and field experiences to their needs.
3. Service Partners: Specialists in strategic planning, training design, event management, localization, and accessibility support clients in optimizing their commercial maturity.

Significance of ACTOverse

The introduction of ACTOverse marks a crucial milestone for ACTO in its efforts to promote excellence in the life sciences field. The platform allows companies to bypass prolonged due diligence processes and complex integrations, resulting in a faster implementation of solutions. Parth Khanna, CEO of ACTO, emphasized the marketplace's role in accelerating the deployment of innovations and AI by bringing together top-tier solution providers.

"By uniting top solution providers and collaborating with them to offer content, data, and services on a digital marketplace, we empower our clients to implement new features more rapidly without the troubles of rigorous evaluations or complicated integrations," stated Khanna.

Benefits for Companies

ACTOverse simplifies how companies in biopharma and medical technology discover and utilize solutions. This facility not only enhances accessibility for commercial learners but also establishes a reliable source of high-quality learning content within the ACTO ecosystem. Businesses can confidently equip their teams with the necessary skills and knowledge to enhance customer interactions.

Sharon Lustig, CEO of the CMR Institute, remarked, "ACTOverse provides commercial learning teams with seamless access to trusted, high-quality learning content directly within ACTO, enabling us to help teams introduce products to the market more swiftly and elevate the standard for on-site performance."

Mark Kroes, CEO of Global Data Support, added, "Data drives personalization. With ACTOverse, we enable clients to leverage market insights, HCP profiles, and patient experience signals to tailor learning experiences without significant effort or integration issues."

Availability and Next Steps

ACTOverse is now available for all ACTO clients who seek to enhance their capabilities in the life sciences space. Interested parties can learn more by visiting the ACTO booth at the Conference Expo Hall during the Veeva Commercial Summit or by checking the ACTO website at www.acto.com/ACTOverse.

For the latest news and updates from ACTO, follow them on LinkedIn or visit their official website. ACTO continues to position itself as a reliable partner for intelligent field excellence across the life sciences, ensuring that companies can provide knowledgeable and confident representatives during healthcare interactions.

In conclusion, the launch of ACTOverse represents a significant advance in the integration of partner solutions within the life sciences sector, offering a streamlined approach to accessing essential resources that drive innovation and performance.